135 related articles for article (PubMed ID: 20693970)
1. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
Horacek JM; Vasatova M; Tichy M; Pudil R; Jebavy L; Maly J
Exp Oncol; 2010 Jul; 32(2):97-9. PubMed ID: 20693970
[TBL] [Abstract][Full Text] [Related]
2. Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.
Horacek JM; Tichy M; Jebavy L; Pudil R; Ulrychova M; Maly J
Exp Oncol; 2008 Jun; 30(2):157-9. PubMed ID: 18566582
[TBL] [Abstract][Full Text] [Related]
3. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
[TBL] [Abstract][Full Text] [Related]
5. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
7. The comparison of cardiac biomarkers positivities in hemodialysis patients without acute coronary syndrome.
Korkmaz H; Saşak G; Celik A; Kurtoğlu E; Gürger M; Bursalı KB; Sahan M
Ren Fail; 2011; 33(6):578-81. PubMed ID: 21663388
[TBL] [Abstract][Full Text] [Related]
8. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation.
Horacek JM; Tichy M; Pudil R; Jebavy L; Zak P; Ulrychova M; Slovacek L; Maly J
Neoplasma; 2008; 55(6):532-7. PubMed ID: 18999883
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients.
Matsumura T; Saito T; Fujimura H; Shinno S
Brain Dev; 2007 Sep; 29(8):496-501. PubMed ID: 17376624
[TBL] [Abstract][Full Text] [Related]
10. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform.
Orak M; Ustündağ M; Güloğlu C; Ozhasenekler A; Alyan O; Kale E
Am J Emerg Med; 2010 Oct; 28(8):891-6. PubMed ID: 20825920
[TBL] [Abstract][Full Text] [Related]
11. Temporal pattern of cardiac troponin I after thoracotomy and lung surgery.
Vikenes K; Andersen KS; Farstad M; Nordrehaug JE
Int J Cardiol; 2004 Sep; 96(3):403-7. PubMed ID: 15301894
[TBL] [Abstract][Full Text] [Related]
12. Automated heart-type fatty acid-binding protein assay for the early diagnosis of acute myocardial infarction.
Kim Y; Kim H; Kim SY; Lee HK; Kwon HJ; Kim YG; Lee J; Kim HM; So BH
Am J Clin Pathol; 2010 Jul; 134(1):157-62. PubMed ID: 20551280
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
14. Cardiac troponins--biochemical markers of cardiac toxicity after cytostatic therapy.
Urbanová D; Urban L; Carter A; Maasova D; Mladosievicova B
Neoplasma; 2006; 53(3):183-90. PubMed ID: 16652186
[TBL] [Abstract][Full Text] [Related]
15. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay.
Ecollan P; Collet JP; Boon G; Tanguy ML; Fievet ML; Haas R; Bertho N; Siami S; Hubert JC; Coriat P; Montalescot G
Int J Cardiol; 2007 Jul; 119(3):349-54. PubMed ID: 17097752
[TBL] [Abstract][Full Text] [Related]
16. Troponin T or troponin I or CK-MB (or none?).
Collinson PO
Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hs-cTnI, hs-cTnT, hFABP and GPBB for identifying early adverse cardiac events in patients presenting within six hours of chest pain-onset.
Shortt CR; Worster A; Hill SA; Kavsak PA
Clin Chim Acta; 2013 Apr; 419():39-41. PubMed ID: 23376465
[No Abstract] [Full Text] [Related]
18. [Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients].
Qin J; Zhang PH; Qian XY; Kang SJ; Luo RC; Wang YG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):930-2. PubMed ID: 18583230
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure.
Nakai K; Nakai K; Nagane Y; Obara W; Sato M; Ohi K; Matsumoto N; Takanashi N; Itoh C
Clin Exp Nephrol; 2004 Mar; 8(1):43-7. PubMed ID: 15067515
[TBL] [Abstract][Full Text] [Related]
20. Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes.
Cavus U; Coskun F; Yavuz B; Ciftci O; Sahiner L; Aksoy H; Deniz A; Ozakin E; Aytemir K; Tokgozoglu L; Kabakci G
J Natl Med Assoc; 2006 Jul; 98(7):1067-70. PubMed ID: 16895274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
